Live Breaking News & Updates on Polly Holland

Stay updated with breaking news from Polly holland. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Covid 19 coronavirus: Did spotlighting a rare potential vaccine side effect put more at risk?


Covid 19 coronavirus: Did spotlighting a rare potential vaccine side effect put more at risk?
15 Apr, 2021 10:19 PM
7 minutes to read
A health worker loads syringes with the Johnson & Johnson vaccine. Photo / AP
New York Times
By: Sheryl Gay Stolberg and Jan Hoffman
Some public health officials fear that the pause on the Johnson & Johnson vaccine may fuel vaccine hesitancy and expose more Americans to a bigger danger: the coronavirus.
To federal health officials, asking states Tuesday
to suspend use of the Johnson & Johnson coronavirus vaccine until they can investigate six extremely rare but troubling cases of blood clots was an obvious and perhaps unavoidable move. ....

United States , Wellesley College , Georgetown University , District Of Columbia , Rupalij Limaye , Jan Hoffman , Rachael Piltch Loeb , Brian Castrucci , Jen Osterheldt , Polly Holland , Kayli Balin , Paul Simon , Maulik Joshi , Angela Rasmussen , Frank Luntz , Global Health Science , Centers For Disease , Los Angeles County Department Of Public Health , Meritus Health In Hagerstown , Drug Administration , Beaumont Foundation , Kaiser Family Foundation , Johns Hopkins Bloomberg School Of Public Health , School Of Global Public Health , Los Angeles County Department , Disease Control ,

Did Spotlighting a Rare Potential Vaccine Side Effect Put More at Risk?


The problem is getting the public to understand relative risk, said Rupali J. Limaye, who studies public health messaging at the Johns Hopkins Bloomberg School of Public Health. She noted that the potential rate of blood clotting in reaction to the vaccine is much smaller than the blood clotting rate for cigarette smokers and for women who use hormonal contraception, although the types of blood clots differ.
Image
A mass vaccination site in San Juan, P.R., in March. Around the country, Johnson & Johnson vaccine recipients were left to grapple with the news, which was especially unsettling for women ages 18 to 48, who accounted for all six cases of blood clots.Credit.Carlos Giusti/Associated Press ....

United States , Georgetown University , District Of Columbia , Rupalij Limaye , Madeleine Ngo , Rachael Piltch Loeb , Brian Castrucci , Jennifer Steinhauer , Jen Osterheldt , Polly Holland , Kayli Balin , Hailey Fuchs , Paul Simon , Maulik Joshi , Angela Rasmussen , Frank Luntz , Global Health Science , Centers For Disease , N Yu School Of Global Public Health , Meritus Health In Hagerstown , Los Angeles County Department Of Public Health , Beaumont Foundation , Wellesley College , Drug Administration , Kaiser Family Foundation , Carlos Giusti Associated ,

Did spotlighting a rare potential side effect of J&J Covid-19 vaccine put more at risk?


WASHINGTON (NYTIMES) - To federal health officials, asking states on Tuesday (April 13) to suspend use of the Johnson & Johnson coronavirus vaccine until they can investigate six extremely rare but troubling cases of blood clots was an obvious and perhaps unavoidable move.
But where scientists saw prudence, public health officials saw a delicate trade-off: The blood clotting so far appears to affect just 1 out of every 1 million people injected with the vaccine, and it is not yet clear if the vaccine is the cause. If highlighting the clotting heightens vaccine hesitancy and bolsters conspiracy theorists, the pause in the end could ultimately sicken - and even kill - more people than it saves. ....

District Of Columbia , United States , Wellesley College , Georgetown University , Rupalij Limaye , Rachael Piltch Loeb , Brian Castrucci , Jen Osterheldt , Polly Holland , Kayli Balin , Paul Simon , Maulik Joshi , Angela Rasmussen , Frank Luntz , Centre For Global Health Science , Los Angeles County Department Of Public Health , Meritus Health In Hagerstown , Drug Administration , Beaumont Foundation , Kaiser Family Foundation , Johns Hopkins Bloomberg School Of Public Health , School Of Global Public Health , Los Angeles County Department , Disease Control , Global Public , Before Tuesday ,